Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Shares Issued (2020 - 2023)

Historic Shares Issued for Cullinan Therapeutics (CGEM) over the last 4 years, with Q2 2023 value amounting to $38.4 million.

  • Cullinan Therapeutics' Shares Issued rose 893310.34% to $38.4 million in Q2 2023 from the same period last year, while for Dec 2023 it was $38.4 million, marking a year-over-year increase of 322940.16%. This contributed to the annual value of $262.7 million for FY2024, which is 58420.34% up from last year.
  • Latest data reveals that Cullinan Therapeutics reported Shares Issued of $38.4 million as of Q2 2023, which was up 893310.34% from -$36000.0 recorded in Q1 2023.
  • Cullinan Therapeutics' 5-year Shares Issued high stood at $267.3 million for Q1 2021, and its period low was -$435000.0 during Q2 2022.
  • Its 4-year average for Shares Issued is $46.0 million, with a median of $1.6 million in 2022.
  • Over the last 5 years, Cullinan Therapeutics' Shares Issued had its largest YoY gain of 893310.34% in 2023, and its largest YoY loss of 10226.7% in 2023.
  • Cullinan Therapeutics' Shares Issued (Quarter) stood at $800000.0 in 2020, then skyrocketed by 33308.5% to $267.3 million in 2021, then plummeted by 100.16% to -$435000.0 in 2022, then surged by 8933.1% to $38.4 million in 2023.
  • Its last three reported values are $38.4 million in Q2 2023, -$36000.0 for Q1 2023, and -$435000.0 during Q2 2022.